1. Home
  2. INCY vs CIB Comparison

INCY vs CIB Comparison

Compare INCY & CIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Incyte Corp.

INCY

Incyte Corp.

N/A

Current Price

$114.90

Market Cap

24.5B

Sector

Health Care

ML Signal

N/A

Logo BanColombia S.A.

CIB

BanColombia S.A.

N/A

Current Price

$81.69

Market Cap

20.9B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
INCY
CIB
Founded
1991
1945
Country
United States
Colombia
Employees
N/A
N/A
Industry
Biotechnology: Commercial Physical & Biological Resarch
Commercial Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
24.5B
20.9B
IPO Year
1994
2025

Fundamental Metrics

Financial Performance
Metric
INCY
CIB
Price
$114.90
$81.69
Analyst Decision
Buy
Hold
Analyst Count
28
11
Target Price
★ $132.17
$90.54
AVG Volume (30 Days)
★ 1.5M
278.2K
Earning Date
10-29-2026
11-09-2026
Dividend Yield
N/A
★ 5.71%
EPS Growth
★ 4173.33
N/A
EPS
★ 0.50
N/A
Revenue
★ $3,394,635,000.00
N/A
Revenue This Year
$17.74
$6.92
Revenue Next Year
$4.38
$8.32
P/E Ratio
$231.80
★ $10.87
Revenue Growth
★ 13.67
N/A
52 Week Low
$89.25
$59.64
52 Week High
$132.60
$105.60

Technical Indicators

Market Signals
Indicator
INCY
CIB
Relative Strength Index (RSI) 41.81 27.35
Support Level $109.78 $77.15
Resistance Level $119.29 $83.43
Average True Range (ATR) 3.73 3.06
MACD -0.53 -1.01
Stochastic Oscillator 3.94 4.20

Price Performance

Historical Comparison
INCY
CIB

About INCY Incyte Corp.

Incyte focuses on the discovery and development of small-molecule drugs. The firm's leading drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly), and oncology drugs Iclusig (chronic myeloid leukemia), Pemazyre (cholangiocarcinoma), Tabrecta (lung cancer), and Monjuvi (diffuse large B-cell lymphoma). The firm's first dermatology product, Opzelura, was approved in 2021 for atopic dermatitis and 2022 for vitiligo. Incyte's pipeline includes an array of oncology and dermatology programs.

About CIB BanColombia S.A.

Grupo Cibest SA is a full service financial group offering a broad range of financial products and services to a diversified individual and corporate clients through subsidiaries. Its network also includes offshore banking subsidiaries in Panama and Puerto Rico, as well as other adjacent businesses. Its products and services include Savings and Investment, Financing, Factoring, Financial and Operating Leases, Capital Markets, Trading, Cash Management, Foreign Currency and Trade Finance, Bancassurance and Insurance, Investment Banking, Trust and Fiduciary Services, Mortgage Lending Business, among others. Its segments include Banking Colombia, Banking El Salvador, Banking Guatemala, International Banking, Leases, All Other and Banking Panama.

Share on Social Networks: